Physician
Exclusive Physicians PLLC
Exclusive Physicians PLLC was paid $28.56M by Medicaid between Jan 2018 and Dec 2024, across 299 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 37% of everything it billed.
33Billing provider infoEXCLUSIVE PHYSICIANS PLLC
FERNDALE, MI 48220
FERNDALE, MI 48220
33aNPI1811226749assigned 12/24/2009
33bProvider typeFamily Medicine Physician
28Total paid$28.56M
24GClaims1,665,638
24DCodes billed299
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Family Medicine Physician providers in Michigan
Rank by total paid#2 of 826
Median peer was paid$98K
This provider vs. median293×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 90,319 | $1.60M | |
| 2019 | 87,748 | $1.52M | |
| 2020 | 151,477 | $2.73M | |
| 2021 | 239,282 | $4.58M | |
| 2022 | 334,943 | $5.48M | |
| 2023 | 403,661 | $7.00M | |
| 2024incomplete | 358,208 | $5.65M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 37% | 122,155 | 103,536 | $10.47M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 6.2% | 27,957 | 22,327 | $1.77M |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 4.6% | 16,380 | 15,919 | $1.32M |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 4.3% | 14,221 | 13,858 | $1.24M |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 3.4% | 8,411 | 8,305 | $978K |
| 99490 | Ccm add 20min | 3.1% | 24,003 | 23,974 | $890K |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 2.2% | 4,259 | 4,133 | $636K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 1.8% | 6,754 | 6,693 | $523K |
| 80074 | 1.5% | 13,296 | 13,126 | $441K | |
| 99487 | Ccm add 20min | 1.5% | 5,688 | 5,671 | $440K |
| 94010 | 1.1% | 18,229 | 17,833 | $301K | |
| 80053 | Comprehensive metabolic panel | <1% | 34,424 | 32,773 | $284K |
287 more codes
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 42,376 | $258K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 3,000 | $241K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 3,234 | $238K |
| 80061 | Lipid panel | <1% | 23,757 | $229K |
| 94690 | <1% | 8,675 | $216K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 3,883 | $210K |
| 93922 | <1% | 4,524 | $204K | |
| 99406 | <1% | 26,897 | $195K | |
| 90837 | Psychotherapy session, about an hour | <1% | 2,085 | $190K |
| 99439 | <1% | 6,575 | $184K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 66,422 | $183K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 2,253 | $179K |
| 93000 | <1% | 20,798 | $172K | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 2,315 | $172K |
| 95250 | <1% | 1,987 | $163K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 1,414 | $160K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 6,010 | $151K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 4,962 | $144K |
| G0506 | Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) | <1% | 20,408 | $142K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 11,221 | $130K |
| 93925 | <1% | 1,063 | $128K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 1,622 | $127K |
| 87652 | <1% | 4,210 | $126K | |
| 99489 | Ccm add 20min | <1% | 2,533 | $124K |
| 87512 | <1% | 4,215 | $120K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 16,543 | $119K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 6,723 | $118K |
| 97535 | Self-care/home management training, each 15 minutes | <1% | 6,391 | $114K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 12,304 | $109K |
| 96160 | <1% | 7,853 | $104K | |
| 90791 | Psychiatric diagnostic evaluation | <1% | 889 | $102K |
| 81002 | <1% | 39,955 | $101K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 10,833 | $99K |
| 92250 | <1% | 4,707 | $98K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 5,396 | $97K |
| 87653 | <1% | 4,024 | $93K | |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | <1% | 3,886 | $91K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 4,261 | $91K |
| 90682 | <1% | 1,581 | $89K | |
| 87481 | <1% | 4,027 | $89K | |
| 99385 | <1% | 909 | $85K | |
| G9001 | Coordinated care fee, initial rate | <1% | 20,024 | $85K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 5,894 | $80K |
| 87799 | <1% | 3,591 | $77K | |
| 87632 | <1% | 499 | $73K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 2,830 | $73K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 2,245 | $73K |
| 99457 | <1% | 2,294 | $69K | |
| 92568 | <1% | 7,380 | $68K | |
| G9008 | Coordinated care fee, physician coordinated care oversight services | <1% | 17,631 | $67K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 983 | $66K |
| 99454 | <1% | 1,998 | $64K | |
| 96127 | <1% | 17,377 | $64K | |
| 87492 | <1% | 1,599 | $61K | |
| 99496 | <1% | 439 | $60K | |
| 97162 | <1% | 982 | $55K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 2,828 | $54K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 1,103 | $53K |
| 82728 | <1% | 5,176 | $52K | |
| 97124 | <1% | 3,283 | $52K | |
| 82607 | <1% | 5,083 | $52K | |
| 82172 | <1% | 4,293 | $51K | |
| 81025 | <1% | 7,675 | $51K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 3,823 | $51K |
| 95800 | <1% | 581 | $50K | |
| 97014 | <1% | 7,147 | $50K | |
| 92551 | <1% | 7,130 | $50K | |
| 87500 | <1% | 3,449 | $49K | |
| 87592 | <1% | 1,604 | $49K | |
| 82746 | <1% | 4,887 | $48K | |
| 84153 | <1% | 3,435 | $47K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 2,689 | $47K |
| 82962 | <1% | 19,048 | $46K | |
| 87641 | <1% | 3,801 | $44K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 2,458 | $44K |
| 87640 | <1% | 3,800 | $44K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 6,398 | $41K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 3,647 | $40K |
| 93015 | <1% | 877 | $39K | |
| 99386 | <1% | 343 | $39K | |
| 84439 | <1% | 5,560 | $38K | |
| 95251 | <1% | 1,937 | $38K | |
| 76830 | Ultrasound, transvaginal | <1% | 693 | $37K |
| 96138 | <1% | 3,248 | $36K | |
| 97163 | <1% | 570 | $34K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 2,995 | $32K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 489 | $30K |
| 82044 | <1% | 6,843 | $30K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 1,824 | $30K |
| 99458 | <1% | 882 | $29K | |
| 36416 | <1% | 23,574 | $29K | |
| 83550 | <1% | 4,320 | $27K | |
| 90686 | <1% | 2,100 | $27K | |
| G9002 | Coordinated care fee, maintenance rate | <1% | 5,756 | $26K |
| 72100 | <1% | 1,054 | $24K | |
| 99051 | <1% | 7,907 | $24K | |
| 82570 | <1% | 6,624 | $23K | |
| 87634 | <1% | 486 | $22K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 489 | $20K |
| 99383 | <1% | 221 | $20K | |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 407 | $18K |
| 85018 | <1% | 9,920 | $18K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,341 | $17K |
| 82985 | <1% | 1,373 | $16K | |
| 99384 | <1% | 154 | $16K | |
| 73562 | <1% | 650 | $15K | |
| 0011A | <1% | 425 | $15K | |
| 99459 | <1% | 982 | $14K | |
| 69210 | <1% | 453 | $13K | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 2,515 | $13K |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 65 | $13K |
| 87486 | <1% | 499 | $13K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 482 | $12K |
| G9007 | Coordinated care fee, scheduled team conference | <1% | 5,182 | $12K |
| 0012A | <1% | 318 | $11K | |
| 90677 | <1% | 174 | $11K | |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 173 | $11K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 272 | $10K |
| 76536 | <1% | 197 | $10K | |
| 99453 | <1% | 835 | $9K | |
| 76770 | <1% | 205 | $9K | |
| 84403 | <1% | 517 | $9K | |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | <1% | 6,580 | $9K |
| 20610 | <1% | 277 | $9K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 4,361 | $9K |
| 99382 | <1% | 94 | $8K | |
| 83014 | <1% | 1,931 | $8K | |
| 86769 | <1% | 237 | $8K | |
| 97035 | <1% | 1,179 | $8K | |
| 90670 | <1% | 551 | $7K | |
| 0001A | <1% | 182 | $7K | |
| G2058 | Chronic care management services, each additional 20 minutes of clinical staff time directed by a physician or other qualified health care professional, per calendar month (list separately in addition to code for primary procedure). (do not report g2058 for care management services of less than 20 minutes additional to the first 20 minutes of chronic care management services during a calendar month). (use g2058 in conjunction with 99490). (do not report 99490, g2058 in the same calendar month as 99487, 99489, 99491)). | <1% | 287 | $6K |
| 0004A | <1% | 173 | $6K | |
| 83540 | <1% | 1,392 | $6K | |
| 73030 | <1% | 282 | $5K | |
| 99495 | <1% | 48 | $5K | |
| 90651 | <1% | 632 | $5K | |
| 97164 | <1% | 127 | $5K | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 4,500 | $5K |
| 72052 | <1% | 129 | $5K | |
| 87498 | <1% | 346 | $5K | |
| 87541 | <1% | 346 | $5K | |
| 87581 | <1% | 346 | $5K | |
| 90673 | <1% | 70 | $5K | |
| 73564 | <1% | 195 | $5K | |
| 84481 | <1% | 364 | $4K | |
| 90715 | <1% | 685 | $4K | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 2,857 | $4K |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 57 | $4K |
| 86580 | <1% | 638 | $4K | |
| 82150 | <1% | 712 | $3K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 64 | $3K |
| 90621 | <1% | 272 | $3K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 103 | $3K |
| 83690 | <1% | 649 | $3K | |
| 80305 | <1% | 366 | $3K | |
| 0002A | <1% | 80 | $3K | |
| G0136 | Administration of a standardized, evidence-based assessment of physical activity and nutrition, 5-15 minutes, not more often than every 6 months | <1% | 269 | $3K |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 553 | $3K |
| 90656 | <1% | 197 | $3K | |
| 90732 | <1% | 35 | $3K | |
| 90619 | <1% | 586 | $3K | |
| 93248 | <1% | 154 | $2K | |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 72 | $2K |
| 86140 | <1% | 598 | $2K | |
| 87807 | <1% | 306 | $2K | |
| 99205 | Prolong outpt/office vis | <1% | 20 | $2K |
| 0134A | <1% | 66 | $2K | |
| 0124A | <1% | 59 | $2K | |
| 0064A | <1% | 55 | $2K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 292 | $2K |
| 85610 | <1% | 645 | $2K | |
| 86141 | <1% | 226 | $2K | |
| 73130 | <1% | 86 | $2K | |
| 85651 | <1% | 586 | $2K | |
| 90632 | <1% | 31 | $2K | |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 26 | $1K |
| 0071A | <1% | 34 | $1K | |
| 90716 | <1% | 186 | $1K | |
| 93246 | <1% | 149 | $1K | |
| 86703 | <1% | 110 | $1K | |
| 82553 | <1% | 126 | $1K | |
| G0444 | Annual depression screening, 5 to 15 minutes | <1% | 7,986 | $1K |
| 99173 | <1% | 6,463 | $952.00 | |
| 82043 | <1% | 221 | $903.18 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 85 | $793.41 |
| 73630 | <1% | 46 | $747.02 | |
| 74022 | <1% | 29 | $740.30 | |
| 73610 | <1% | 28 | $625.39 | |
| 93244 | <1% | 39 | $569.66 | |
| 99397 | <1% | 13 | $558.80 | |
| 90707 | <1% | 158 | $526.12 | |
| 84550 | <1% | 151 | $431.55 | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 318 | $424.93 |
| 0003A | <1% | 12 | $397.45 | |
| 73502 | <1% | 14 | $385.42 | |
| 83655 | <1% | 43 | $380.99 | |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | <1% | 181 | $374.71 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 344 | $374.46 |
| 86431 | <1% | 84 | $345.37 | |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | <1% | 693 | $319.60 |
| 96120 | <1% | 18 | $286.09 | |
| 95012 | <1% | 24 | $210.72 | |
| 90662 | <1% | 46 | $194.87 | |
| D0190 | <1% | 12 | $186.37 | |
| 99072 | <1% | 10,942 | $87.50 | |
| 99188 | <1% | 12 | $85.92 | |
| 82550 | <1% | 17 | $83.53 | |
| G0008 | Administration of influenza virus vaccine | <1% | 169 | $62.57 |
| 96146 | <1% | 235 | $38.43 | |
| 3008F | <1% | 108,019 | $37.31 | |
| 3074F | <1% | 62,828 | $29.08 | |
| 3078F | <1% | 44,387 | $26.89 | |
| 2014F | <1% | 19,495 | $23.83 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 30,257 | $22.38 |
| 1005F | <1% | 21,297 | $18.67 | |
| S9441 | Asthma education, non-physician provider, per session | <1% | 19,041 | $18.66 |
| G8539 | Functional outcome assessment documented as positive using a standardized tool and a care plan based on identified deficiencies is documented within two days of the functional outcome assessment | <1% | 21,362 | $18.66 |
| 3079F | <1% | 39,713 | $18.61 | |
| 3016F | <1% | 20,649 | $17.92 | |
| 3075F | <1% | 19,179 | $14.19 | |
| 94664 | <1% | 56 | $13.68 | |
| J7611 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | <1% | 116 | $5.94 |
| 1111F | <1% | 4,210 | $3.32 | |
| 3077F | <1% | 14,001 | $2.23 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 12 | $1.15 |
| 1000F | <1% | 25,261 | $0.28 | |
| 98967 | <1% | 43 | $0.04 | |
| 98966 | <1% | 15 | $0.03 | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 1,817 | $0.02 |
| 2000F | 0% | 15,678 | $0.00 | |
| 3080F | 0% | 12,018 | $0.00 | |
| 3048F | 0% | 9,535 | $0.00 | |
| G8754 | Most recent diastolic blood pressure < 90 mmhg | 0% | 4,801 | $0.00 |
| 97010 | 0% | 3,173 | $0.00 | |
| 4450F | 0% | 17,318 | $0.00 | |
| 91301 | 0% | 141 | $0.00 | |
| 4011F | 0% | 29 | $0.00 | |
| 3044F | 0% | 11,859 | $0.00 | |
| 90744 | 0% | 27 | $0.00 | |
| 1126F | 0% | 396 | $0.00 | |
| 90696 | 0% | 112 | $0.00 | |
| 3049F | 0% | 7,228 | $0.00 | |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 0% | 170 | $0.00 |
| 4010F | 0% | 330 | $0.00 | |
| 1170F | 0% | 924 | $0.00 | |
| 3052F | 0% | 425 | $0.00 | |
| 3066F | 0% | 557 | $0.00 | |
| 91307 | 0% | 67 | $0.00 | |
| 90680 | 0% | 51 | $0.00 | |
| 90697 | 0% | 80 | $0.00 | |
| 90647 | 0% | 40 | $0.00 | |
| 3120F | 0% | 65 | $0.00 | |
| 90723 | 0% | 15 | $0.00 | |
| G8755 | Most recent diastolic blood pressure >= 90 mmhg | 0% | 306 | $0.00 |
| 90698 | 0% | 28 | $0.00 | |
| 3061F | 0% | 12 | $0.00 | |
| 4008F | 0% | 15 | $0.00 | |
| G8753 | Most recent systolic blood pressure >= 140 mmhg | 0% | 396 | $0.00 |
| 2028F | 0% | 4,596 | $0.00 | |
| 2026F | 0% | 5,313 | $0.00 | |
| G8752 | Most recent systolic blood pressure < 140 mmhg | 0% | 4,143 | $0.00 |
| 3050F | 0% | 6,142 | $0.00 | |
| G9458 | Patient documented as tobacco user and received tobacco cessation intervention (must include at least one of the following: advice given to quit smoking or tobacco use, counseling on the benefits of quitting smoking or tobacco use, assistance with or referral to external smoking or tobacco cessation support programs, or current enrollment in smoking or tobacco use cessation program) if identified as a tobacco user | 0% | 22,213 | $0.00 |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | 0% | 943 | $0.00 |
| 2022F | 0% | 5,316 | $0.00 | |
| 3051F | 0% | 1,132 | $0.00 | |
| 90461 | 0% | 3,178 | $0.00 | |
| 90633 | 0% | 600 | $0.00 | |
| 1159F | 0% | 1,807 | $0.00 | |
| 1160F | 0% | 1,809 | $0.00 | |
| 3046F | 0% | 1,741 | $0.00 | |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 680 | $0.00 |
| 90713 | 0% | 55 | $0.00 | |
| 3288F | 0% | 960 | $0.00 | |
| 99078 | 0% | 1,522 | $0.00 | |
| 1090F | 0% | 1,604 | $0.00 | |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 456 | $0.00 |
| 3045F | 0% | 196 | $0.00 | |
| 91300 | 0% | 352 | $0.00 | |
| 90710 | 0% | 339 | $0.00 | |
| 90700 | 0% | 241 | $0.00 | |
| 3023F | 0% | 32 | $0.00 | |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | 0% | 27 | $0.00 |
| 91312 | 0% | 52 | $0.00 | |
| 91313 | 0% | 55 | $0.00 | |
| 90734 | 0% | 85 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialNAMAN, GREG (OWNER)
| Provider | Location | Paid |
|---|---|---|
| Epic Medical Lab PLLC | Ferndale, MI | $157.43 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.